Pituitary metastasis from renal cell carcinoma that progressed on sorafenib - Abstract

Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib.

Herein we present a case of an advanced clear-cell renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial response while on sorafenib.

Written by:
Yang L, Yu SY, Hu GY.   Are you the author?
Oncology Center, Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan, Hubei 430030, P. R. China.

Reference: Chin J Cancer. 2012 Dec 7. Epub ahead of print.
doi: 10.5732/cjc.012.10184


PubMed Abstract
PMID: 23237217

UroToday.com Renal Cancer Section